Table 2.
Results of individual regression models by cohort, each adjusted for age and gender.
| Variable | Original cohort (PLT) | Offspring (PRPPC) | Third Generation (PLT) | Third Generation (MPV) | ||||
|---|---|---|---|---|---|---|---|---|
| Parameter | P-value | Parameter | P-value | Parameter | P-value | Parameter | P-value | |
| Gender (female)a | 30.88b | <.0001 | 825.82 | 0.0008 | 23.35 | <.0001 | 0.0687 | 0.0657 |
|
| ||||||||
| Age, yearsc | 0.38 | 0.3574 | −37.24 | 0.0026 | −0.19 | 0.1477* | −0.0044 | 0.041 |
|
| ||||||||
| Hypertension medication | −2.93 | 0.5435 | 269.39 | 0.4049 | 10.06 | 0.0008* | −0.0094 | 0.851 |
|
| ||||||||
| Smoked cigarettes regularly (last year) | 34.90 | <.0001 | 1,377.61 | <.0001 | 14.83 | <.0001 | −0.1147 | 0.0474 |
|
| ||||||||
| Current smokerd | 35.28 | <.0001 | 1,338.98 | 0.0002 | 15.35 | <.0001 | −0.1300 | 0.0278 |
|
| ||||||||
| Former smokerd | 6.96 | .1617 | 81.16 | 0.7668 | 11.17 | 0.2332 | −0.0900 | 0.5462 |
|
| ||||||||
| Pack years (ln) | 7.79 | 0.0403 | 574.98 | <.0001 | --- | --- | ||
|
| ||||||||
| Alcohol use | 1.54 | 0.755 | 31.95 | 0.9052* | −3.09 | 0.2708 | −0.0312 | 0.5042 |
|
| ||||||||
| Aspirin use | 1.09 | 0.8309* | 476.81 | 0.0962 | 0.35 | 0.9172 | 0.1287 | 0.0204 |
|
| ||||||||
| Diabetes (prevalence) | 1.85 | 0.8043 | −1,479.86 | 0.0023 | 4.97 | 0.2722* | 0.1572 | 0.0369 |
|
| ||||||||
| Diabetes medication | −11.82 | 0.1987 | −2,498.73 | 0.0003 | 12.39 | 0.0297 | 0.0928 | 0.3284 |
|
| ||||||||
| PE/DVT (prevalence) | ---e | 1,043.95 | 0.6891 | 35.22 | 0.0045 | −0.0837 | 0.685 | |
|
| ||||||||
| CVD (prevalence) | −3.67 | 0.4797 | −383.07 | 0.3675 | 1.25 | 0.8588** | 0.0686 | 0.5579 |
|
| ||||||||
| CVA (prevalence) | −13.01 | 0.0984 | −1,171.41 | 0.231 | −10.88 | 0.3916 | 0.0238 | 0.9104 |
|
| ||||||||
| SBP (mmHg) | 0.06 | 0.6069 | 22.55 | 0.0011* | 0.37 | <.0001* | 0.0004 | 0.7866 |
|
| ||||||||
| DBP (mmHg) | −0.19 | 0.3895 | 49.74 | <.0001 | 0.64 | <.0001* | 0.0004 | 0.8458 |
|
| ||||||||
| HDL (mg/dL) | 0.30 | 0.0721 | −1.75 | 0.8441* | −0.16 | 0.0235** | −0.0008 | 0.4884 |
|
| ||||||||
| LDL (mg/dL) | --- | 22.26 | <.0001 | 0.28 | <.0001 | −0.0016 | 0.0084 | |
|
| ||||||||
| Triglycerides (mg/dL) | --- | 4.42 | 0.0003 | 0.09 | <.0001 | −0.0003 | 0.0265 | |
|
| ||||||||
| Total cholesterol (mg/dL) | 0.23 | 0.0001 | 25.33 | <.0001 | 0.26 | <.0001*** | −0.0020 | 0.0003 |
|
| ||||||||
| PLT(×103/uL) | --- | --- | --- | −0.0069 | <.0001 | |||
|
| ||||||||
| MPV (fL) | --- | --- | −25.04 | <.0001 | --- | |||
|
| ||||||||
| BMI | −0.06 | 0.902 | 34.65 | 0.1592 | 1.03 | <.0001** | 0.0053 | 0.1033 |
|
| ||||||||
| Antiplatelets | −9.86 | 0.4558 | −1,335.37 | 0.5097 | --- | --- | ||
|
| ||||||||
| Anticoagulants | 4.56 | 0.7678 | −1,573.50 | 0.2122 | --- | --- | ||
Adjusted for age only,
Values in bold are significant after Bonferroni correction (p<6.67×10−4),
Adjusted for gender only,
“Current” and “former” smoking were part of a three-level variable in an individual regression model, with “never” smoker considered the referent value.
See “Methods” section for more.
“---” indicates PE/DVT, LDL cholesterol, triglycerides, PLT, MPV, pack years, or antiplatelets and anticoagulants were unavailable for these exams.
See “Methods” section for more.
,**,*** indicates significant interaction term with gender (*0.01≤p<0.05, **0.001≤p<0.01, ***p<0.001)